4 High-Yield Stocks Offer Up to 9.76% for Roth IRAs
Updated
Updated · 24/7 Wall St. · Sep 14
4 High-Yield Stocks Offer Up to 9.76% for Roth IRAs
1 articles · Updated · 24/7 Wall St. · Sep 14
Summary
Ares Capital, VICI Properties, Altria and Pfizer were singled out as Roth IRA candidates because their largely ordinary-income dividends can compound tax-free, with yields ranging from 6.16% to 9.76%.
Ares leads on income at 9.76%, supported by $1.92 annualized dividends, 17 years of stable or rising regular payouts and $359 million of Q2 net investment income, though non-accruals rose to 2.4% and NAV slipped.
VICI yields 7.28% after lifting its quarterly dividend to $0.46, with Q2 AFFO of $0.62, 100% occupancy and a 39.6-year average lease term, while Altria yields 6.16% after its 60th increase in 56 years.
Pfizer yields 6.22% with a $0.43 quarterly payout, backed by Q1 revenue growth of 5.4% and a fifth straight EPS beat, even as 2026 faces a roughly $1.5 billion hit from generic and biosimilar competition.
Together, the four span private credit, gaming real estate, tobacco and big pharma, offering a diversified high-yield basket whose main appeal is avoiding annual tax drag inside a Roth IRA.